People · Operator

Dan S. Zabrowski

Named in public records as an officer, director or promoter · active 2018–2019 · Biotechnology

1
Companies
2
Filings
$100.2M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Omniome, Inc.BiotechnologySeries C$100.2M$2.5B2018
Operator network

Dan S. Zabrowski at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

CATHERINE S. LEE · 2 companies · 1 sharedCATHERINE S. LEEKandaswamy Vijayan · 2 companies · 1 sharedKandaswamy VijayanArnold S. Oliphant · 1 companies · 1 sharedArnold S. OliphantBoris S. Nikolic, M.D. · 1 companies · 1 sharedBoris S. Nikolic,…David S. Cruikshank · 1 companies · 1 sharedDavid S. Cruiksha…David S. Mullarkey · 1 companies · 1 sharedDavid S. MullarkeyJohn S. Murphy, Ph.D. · 1 companies · 1 sharedJohn S. Murphy, P…Kelly S. Perez · 1 companies · 1 sharedKelly S. PerezKen S. Song, M.D., Ph.D. · 1 companies · 1 sharedKen S. Song, M.D.…Kim S. Kamdar, Ph.D. · 1 companies · 1 sharedKim S. Kamdar, Ph…Michael S. Yi · 1 companies · 1 sharedMichael S. YiMillard Y Chan · 1 companies · 1 sharedMillard Y ChanOmniome, Inc. · $100.2M raisedOmniome, Inc.Dan S. ZabrowskiDZ
Dan S. Zabrowski Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Dan S. Zabrowski on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
CATHERINE S. LEE12
Kandaswamy Vijayan12
David S. Mullarkey11
Ken S. Song, M.D., Ph.D.11
Kelly S. Perez11
Arnold S. Oliphant11
David S. Cruikshank11
Michael S. Yi11
Boris S. Nikolic, M.D.11
Millard Y Chan11
John S. Murphy, Ph.D.11
Kim S. Kamdar, Ph.D.11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.